COMPOSITION AND METHOD FOR EFFICIENT DELIVERY OF NUCLEIC ACIDS TO CELLS USING CHITOSAN
There is disclosed a composition and a method for the efficient non-viral delivery of nucleic acids to cells using chitosan. In order to achieve high efficiency of transfection, the composition contains a nucleic acid and a chitosan that has the following physico-chemical properties: a combination of a number-average molecular weight between 8 kDa and 185 kDa and a degree of deacetylation between 72% and 92%. The chitosan molecule can also present additional physiochemical properties such as a block distribution of acetyl groups obtained by a heterogeneous treatment of chitin, and/or a polydispersity index between 1.4 and 7.0. By correctly controlling these parameters, efficient delivery systems may be produced that are effective when optimized for different conditions such as the pH of transfection media and amine-to-phosphate ratio.
1 . A composition comprising chitosan and a nucleic acid sequence for delivery of said nucleic acid sequence into cells, wherein the chitosan has a number-average molecular weight (M n ) between 8 kDa and 185 kDa and a degree of deacetylation between 72% and 92%.
2 . The composition of claim 1 wherein said chitosan has a block distribution of acetyl groups.
3 . The composition of claim 1 , wherein said chitosan has a polydispersity between 1.4 and 7.0.
4 . The composition of claim 1 , wherein said composition has an amine:phosphate ratio of at least 5:1.
5 . The composition of claim 4 , wherein said amine:phosphate ratio is at least 7:1.
6 . The composition of claim 8 , wherein said amine:phosphate ratio is 10:1.
7 . The composition of claim 1 , further comprising a transfection media having a pH varying from 6.5 to 7.1.
8 . The composition of claim 7 , wherein the pH of said transfection media is 6.5.
9 . The composition of claim 1 , wherein said chitosan has been prepared by chemical or enzymatic hydrolysis.
10 . The composition of claim 1 , wherein the nucleic acid sequence is a deoxyribonucleic acid sequence.
11 . The composition of claim 1 , wherein the nucleic acid sequence is a ribonucleic acid sequence.
12 . The composition of claim 1 , wherein the nucleic acid sequence is a circular plasmid deoxyribonucleic acid sequence.
13 . The composition of claim 1 , wherein the composition is a dried powder.
14 . The composition of claim 1 wherein the composition is a particular suspension in aqueous media.
15 . A method for delivering a nucleic acid sequence into a cell comprising the step of contacting the composition of claim 1 with said cell.
16 . The method of claim 15 , wherein said cell is an isolated cell in culture.
17 . The method of claim 16 , wherein said isolated cell is a primary cell, a transformed cell or an immortalized cell.
18 . The method of claim 15 , wherein said nucleic acid sequence codes for a polypeptide.
19 . The method of claim 15 , wherein said nucleic acid sequence is an antisense nucleic acid sequence.
20 . The method of claim 15 , wherein said nucleic acid sequence is a small interfering ribonucleic acid sequence.
21 . The method of claim 15 , wherein said cell is a mammalian cell.
22 . The method of claim 21 , wherein said mammalian cell is a non-human mammalian cell.
23 - 42 . (canceled)